LYEL – lyell immunopharma, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

LYEL

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/9

07:01 am

lyel

Lyell Immunopharma (NASDAQ:LYEL) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.

Medium Report

Lyell Immunopharma (NASDAQ:LYEL) was upgraded by analysts at HC Wainwright from a "neutral" rating to a "buy" rating.

Report

12/9

06:14 am

lyel

Lyell Immunopharma upgraded to Buy from Neutral at H.C. Wainwright

Medium Report

Lyell Immunopharma upgraded to Buy from Neutral at H.C. Wainwright

Report

12/9

06:14 am

lyel

Lyell Immunopharma upgraded to Buy from Neutral at H.C. Wainwright

Medium Report

Lyell Immunopharma upgraded to Buy from Neutral at H.C. Wainwright

Report

11/24

07:19 am

lyel

Lyell Immunopharma (NASDAQ:LYEL) had its "neutral" rating reaffirmed by analysts at HC Wainwright.

High Report

Lyell Immunopharma (NASDAQ:LYEL) had its "neutral" rating reaffirmed by analysts at HC Wainwright.

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.